programs and events

UPCOMING EVENTS IN YOUR AREA ABOUT AMVUTTRA® (vutrisiran)

Learn about AMVUTTRA, a treatment for the polyneuropathy caused by hATTR amyloidosis in adults.

Find an event in your area.

Patient Educational Event

Rocky Hill, Connecticut
July 11, 2025
6:30 PM to 8:00 PM ET
Hear from an Alnylam Patient Education Liaison Kathy, joined by Patient Ambassador Gary, treated with AMVUTTRA, and Dr. Naveen Bellam, a healthcare professional experienced in the management of ATTR-CM
Register

Patient Educational Event

South Easton, Massachusetts
July 16, 2025
6:00 PM to 7:30 PM ET
Hear from an Alnylam Patient Education Liaison Kathy, joined by Patient Ambassador Kelly, treated with AMVUTTRA, and Dr. Abdul Bikak, a healthcare professional experienced in the management of ATTR-CM
Register

Patient Educational Event

Sacramento, California
July 19, 2025
12:30 PM to 2:00 PM PT
Hear from an Alnylam Patient Education Liaison Rita, joined by Patient Ambassador Kelly, treated with AMVUTTRA, and Dr. Nancy Luo, a healthcare professional experienced in the management of ATTR-CM
Register

Patient Educational Event

Jamaica, New York
July 29, 2025
4:00 PM to 5:30 PM ET
Hear from an Alnylam Patient Education Liaison Christopher, joined by Patient Ambassador Kelly, treated with AMVUTTRA, and Dr. Olakunle Akinboboye, a healthcare professional experienced in the management of ATTR-CM
Register

IMPORTANT SAFETY INFORMATION

What are the most important things I should know about AMVUTTRA® (vutrisiran)?

AMVUTTRA can cause low vitamin A levels

Treatment with AMVUTTRA lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.  

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking AMVUTTRA, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of AMVUTTRA?

The most common side effects of AMVUTTRA were pain in the arms or legs, pain in the joints, shortness of breath, and low vitamin A levels.

These are not all the possible side effects of AMVUTTRA. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

For additional information about AMVUTTRA, please see the full Prescribing Information.

Indications

What is AMVUTTRA?

AMVUTTRA is a prescription medicine that treats the:

  • cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR‑CM) in adults to reduce heart-related death, hospital stays and urgent visits.
  • polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR‑PN) in adults.

For additional information about AMVUTTRA, please see the full Prescribing Information.

Footer Waves Left Footer Waves Right